Neuroscience
Traumatic Brain Injury
100%
Neurotrauma
100%
Blood Brain Barrier
77%
In Vivo
34%
Alzheimer's Disease
32%
Cognitive Disorders
32%
CCR5
27%
Myelin
27%
Regulator Protein
27%
In Vitro
26%
Agonist
24%
Cycloserine
24%
Magnetic Resonance Imaging
23%
Macrophage
21%
Microglia
20%
Phagocytosis
19%
Paraoxon
18%
Closed Head Injury
17%
Chemokine Receptor
16%
Striatum
16%
Electroporation
15%
Phagocyte
14%
Organophosphate
14%
Wallerian Degeneration
14%
Docosahexaenoic Acid
13%
Aspartic Acid
13%
CXCR4
13%
CC Chemokine Receptors
13%
Cannabinoid 2 Receptor
13%
Nerve Fiber Regeneration
13%
Keyphrases
Traumatic Brain Injury
82%
C-C Chemokine Receptor Type 5 (CCR5)
41%
Blood-brain Barrier
40%
Neuroinflammation
34%
C-X-C Chemokine Receptor Type 4 (CXCR4)
27%
Alzheimer's Disease Model
27%
In Vitro Study
27%
D-cycloserine
24%
Paraoxon
19%
Brain Injury
18%
N-methyl-D-aspartate Receptor (NMDAR)
18%
Closed Head Injury
17%
Chemokine Receptor
16%
Cognitive Deficits
15%
Improved Outcomes
15%
Microglia
15%
Cellular Response
14%
Organophosphate
14%
Rat Study
13%
Exogenous Ligands
13%
Myelin Debris
13%
Phagocytic Clearance
13%
Macrophages
13%
Endogenous Ligand
13%
Isoxazol
13%
Insulin Receptor Pathway
13%
GLP-1 Receptor Agonist
13%
CB2 Receptor
13%
Recovery after Stroke
13%
Insulin
13%
Pharmacology, Toxicology and Pharmaceutical Science
Traumatic Brain Injury
65%
Mouse
60%
Blood-Brain Barrier
40%
Mouse Model
36%
Cycloserine
24%
Injury
23%
Nervous System Inflammation
20%
Alzheimer's Disease
18%
Head Injury
18%
Paraoxon
18%
Chemokine Receptor
17%
Brain Injury
15%
Organophosphate
14%
Serine
13%
Beta Chemokine
13%
Cannabinoid 2 Receptor
13%
Cognitive Defect
13%
Implant
13%
Chemotherapy
13%
Neurotoxicity
13%
Alfacalcidol
13%
Advanced Glycation End Product
13%
Insulin Receptor
13%
Aspartic Acid
13%
Methotrexate
13%
Amnesia
13%
Interleukin 1beta Converting Enzyme
13%
Cisplatin
11%
Receptor
10%
Plerixafor
10%